» Articles » PMID: 32801028

An Audit of Community-acquired Pneumonia Antimicrobial Compliance Using an Intervention Bundle in an Irish Hospital

Overview
Date 2020 Aug 18
PMID 32801028
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Hospitalisations with community-acquired pneumonia (CAP) are often not managed in accordance with antimicrobial guidelines. This study aimed to assess whether guideline-driven antimicrobial prescribing for CAP can be improved using an intervention bundle. Secondary measures assessed were hospital length of stay (LOS), mortality, duration of intravenous antibiotics and total antibiotics, improved uptake of appropriate investigations, and documentation of CURB-65 score.

Methods: A retrospective cohort of hospitalised CAP patients from August-September 2018 was compared with a post-intervention prospective cohort from May-June 2019. The intervention bundle included a mobile audience response system, promotion of the antimicrobial app, development of a physical card with local guidelines, and incorporating CURB-65 into the unscheduled admission proforma. Local guidelines are in keeping with British Thoracic Society CAP guidelines.

Results: A total of 69 adult patients (aged >18 years) were included in the study (37 retrospective, 32 prospective). Overall compliance with local CAP guidelines improved from 21.6% to 62.5% (P < 0.001). No difference in initial intravenous antibiotic duration was seen (median 4 days vs. 4 days; P = 0.70) and total antibiotic duration was significantly shorter in the post-intervention group (median 9 days vs. 7 days; P = 0.01). No difference in LOS or mortality was seen between the groups. Documentation of CURB-65 improved from 5.4% to 46.9% (P < 0.001). Uptake of streptococcal urinary antigen testing improved from 18.9% to 40.6% (P = 0.024).

Conclusions: A simple, low-cost quality improvement bundle can significantly increase appropriate antimicrobial prescribing and shorten the total antibiotic duration.

Citing Articles

Accordance of Registered Drug Packages with Guideline-Recommended Treatment Durations for Community-Acquired Pneumonia-A New Antibiotic Stewardship Target?.

Prusac M, Hadziabdic M, Rusic D, Modun D Antibiotics (Basel). 2024; 13(6).

PMID: 38927212 PMC: 11201020. DOI: 10.3390/antibiotics13060546.


Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit.

Luthi-Corridori G, Roth A, Boesing M, Jaun F, Tarr P, Leuppi-Taegtmeyer A J Clin Med. 2024; 13(2).

PMID: 38276080 PMC: 10816545. DOI: 10.3390/jcm13020574.


Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department.

Lorentzen M, Rosenvinge F, Lassen A, Graumann O, Laursen C, Mogensen C BMC Infect Dis. 2023; 23(1):580.

PMID: 37670282 PMC: 10481610. DOI: 10.1186/s12879-023-08565-6.


A Service Evaluation of Adherence with Antimicrobial Guidelines in the Treatment of Community-Acquired Pneumonia Before and During the SARS-CoV-2 Outbreak.

Howley F, Keating D, Kelly M, OConnor R, ORiordan R SN Compr Clin Med. 2022; 4(1):225.

PMID: 36258797 PMC: 9559268. DOI: 10.1007/s42399-022-01311-0.


Antimicrobial prescribing and outcomes of community-acquired pneumonia in Australian hospitalized patients: a cross-sectional study.

Robert L, Mark V, Moayed A, Nivashen A, Vinod R, Sophie P J Int Med Res. 2021; 49(11):3000605211058366.

PMID: 34826375 PMC: 8647258. DOI: 10.1177/03000605211058366.


References
1.
Alexander C, Crescini W, Juskewitch J, Lachman N, Pawlina W . Assessing the integration of audience response system technology in teaching of anatomical sciences. Anat Sci Educ. 2009; 2(4):160-6. PMC: 2802184. DOI: 10.1002/ase.99. View

2.
Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

3.
Lim W, Woodhead M . British Thoracic Society adult community acquired pneumonia audit 2009/10. Thorax. 2011; 66(6):548-9. DOI: 10.1136/thoraxjnl-2011-200081. View

4.
Al-Abri S, Al-Maashani S, Memish Z, Beeching N . An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines. J Infect Public Health. 2012; 5(3):250-6. DOI: 10.1016/j.jiph.2012.03.002. View

5.
Lim W, van der Eerden M, Laing R, Boersma W, Karalus N, Town G . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58(5):377-82. PMC: 1746657. DOI: 10.1136/thorax.58.5.377. View